PEMF should not be described as something that simply “regrows cartilage” or reverses cartilage damage on its own. Cartilage health is complex, and damage can involve changes in the cartilage matrix, joint inflammation, mechanical loading, age, injury history and wider joint function. However, PEMF may be relevant to cartilage health because it has been studied in relation to some of the cells and processes involved in cartilage maintenance. In one study using cultured human chondrocytes, short-duration PEMF exposure was associated with improvements in chondrocyte viability, extracellular matrix component production and cell multiplication. [1]
Another study used human cartilage explants taken from people with osteoarthritis and found that PEMF exposure increased proteoglycan synthesis and helped counteract the catabolic effect of IL-1β, an inflammatory molecule linked with cartilage breakdown. [2]
PEMF has also been explored in a clinical cartilage-repair setting. In one study, people undergoing matrix-assisted autologous chondrocyte implantation for knee cartilage lesions received PEMF after surgery, with researchers reporting improved clinical outcomes compared with the control group. [3]
In simple terms, PEMF may be best understood as a tool that may support some of the biological processes involved in cartilage maintenance, joint cushioning and recovery. It should be viewed as part of a wider cartilage-support routine rather than a standalone cartilage-regeneration treatment.